Blair-Sherlock supports HB5492 to mandate insurance for 12-month hormone therapy prescriptions

Rep. Diane Blair-Sherlock (D-46th) voted in favor of HB5492 on May 31, 2026, during the 104th General Assembly. The Illinois House approved the measure 75-39, according to the Illinois House.

The official summary of HB5492 states: "PRESCRIPTION HORMONE THERAPY."

This overview is based on a review of the bill text and includes clarification of key components.

If enacted, this legislation will require that, starting Jan. 1, 2028, most individual and group health insurance plans in Illinois, along with state employee and Medicaid coverage, provide up to a 12-month supply of prescribed hormone therapy and associated self-administration supplies when requested from in-network providers and dispensed in a single instance. The measure defines eligible hormone therapies (excluding glucagon-like peptide-1 drugs), permits medical plan drug management practices, restricts multiple 12-month refills in a calendar year, and outlines requirements for accessing out-of-network providers when needed. The bill further stipulates that, barring exceptions, pharmacists and other dispensing providers must furnish up to a full year's supply of hormone therapy at the request of the patient.

HB5492's action history includes: 'Senate Floor Amendment No. 2 House Concurs.'

Blair-Sherlock holds an AA from College of DuPage earned in 1985, a BS from Northern Illinois University completed in 1987, and a JD from John Marshall Law School achieved in 1993.

A member of the Democratic Party, Blair-Sherlock was elected in 2023 to represent Illinois House District 46, succeeding Deborah Conroy in the role.

Legislation in Illinois goes through a multi-step legislative process covering introduction in the House or Senate, committee hearings, floor debate, and votes in each chamber, before being sent to the governor for enactment or veto. Each biennial session sees thousands of bills introduced, but only a limited number are enacted into law by the General Assembly.